REGENPRP
LIVE

Serial Number

86760906

Owner

RegenLab USA LLC

Attorney

Lindsay Kaplan

Filing Date

Sep 18, 2015

Add to watchlist:

No watchlists yet
View on USPTO

REGENPRP Trademark

Serial Number: 86760906

REGENPRP is a trademark filed by RegenLab USA LLC on September 18, 2015. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

RegenLab USA LLC (60 trademarks)

95 Greene Street

Entity Type: 16

REGEN LAB SA (31 trademarks)

En Budron B2

Entity Type: 99

Trademark Details

Filing Date

September 18, 2015

Registration Date

Not Registered

Published for Opposition

May 23, 2023

Goods & Services

medical, cosmetic and beauty services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; medical, cosmetic and beauty services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to mesotherapy, to hyaluronic acid, chitosan or silk, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silk

advertising services; business management and administration; arranging and conducting of business fairs, conferences, meetings, competitions, and exhibitions, all of the foregoing for commercial and advertising purposes; conducting on-line trade show exhibitions, in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells; arranging and conducting of fairs and exhibitions for business and advertising purposes; organization of business conventions; sales promotion services for others; business consulting and information services; providing business information in the field of medical and scientific research, medical technology, and surgery; providing business information in the field of office work; providing marketing assistance; providing advertising information, commercial office management information, and information in the field of the rental of advertising space; distribution of advertising materials in the nature of pamphlets, newspapers and periodicals for advertising purposes; electronic commerce services, namely, providing information on products of others via telecommunication networks for advertising, business management, business administration, advertising and marketing purposes; procuring of contracts for the purchase and sale of goods; advertising services, namely, arranging newspaper subscriptions for others; telemarketing services; business research services, namely, market research studies, economic feasibility studies, conducting opinion polls, and business statistical research; advertising services, namely, direct mail advertising and dissemination and distribution of advertising material, namely, leaflets and printed matter, targeted toward the general public and healthcare professionals; equipment advertising, namely, advertising services in the nature of internet advertising, television advertising, telephone advertising, distribution of leaflets and promotional materials, for medical devices, kits, centrifuges, tubes, syringes, needles, solutions and any material used in the field of tissue and cellular regeneration and rejuvenation, regenerative medicine, isolation and application of a patient's own platelets and cells via electronic media and printed materials; database management, namely, management of databases containing business records for others; providing business advice and business information in the field of medical and scientific research, medical technology and surgery; business consultancy; conducting business audits in the field of medical and scientific research, medical technology and surgery; business development services; providing business information related to the content of media, computer file management, data processing, including word processing, collection and systematization of data in a database or a database storage, and classification and archiving of data, all the foregoing for business purposes

educational services, namely, design, organization and conducting colloquia, seminars, symposia, educational conferences, educational conventions, and discussion fora in real time, over Internet-type networks or Intranet-type networks, and other events for educational purposes in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; Educational services, namely, design, organization and conducting colloquia, seminars, symposia, educational conferences, educational conventions, and discussion fora in real time, over Internet-type networks or Intranet-type networks, and other events for educational purposes in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, hyaluronic acid, chitosan or silk, to mesotherapy, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silk

research services, namely, scientific research studies in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; research services, namely, scientific research studies in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to hyaluronic acid, chitosan or silk, to mesotherapy, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silk; research services, namely, scientific research studies in the field of platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 22, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
Jan 20, 2026 EEXT
SOU EXTENSION 5 FILED
Jan 19, 2026 EXT5
DIVISIONAL PROCESSING COMPLETE
Aug 8, 2025 DPCC
DIVISIONAL REQUEST RECEIVED
Aug 1, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 1, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Aug 1, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 17, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 17, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 22, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 21, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 21, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 18, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 18, 2024 EEXT
SOU EXTENSION 1 GRANTED
Jun 15, 2024 EX1G
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2024 EXRA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 10, 2024 AITU
ASSIGNED TO EXAMINER
May 29, 2024 DOCK
NOTICE OF REVIVAL - E-MAILED
Feb 20, 2024 NREV
PETITION TO REVIVE-GRANTED
Feb 20, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 20, 2024 PROA
ABANDONMENT - NO USE STATEMENT FILED
Feb 19, 2024 ABN6
SOU EXTENSION 1 FILED
Jan 18, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2023 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 17, 2023 ERFR
ASSIGNED TO EXAMINER
Feb 21, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 20, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Dec 20, 2022 EWOR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 19, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 19, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 19, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 19, 2022 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 19, 2022 GNFN
FINAL REFUSAL E-MAILED
Dec 19, 2022 GNFR
FINAL REFUSAL WRITTEN
Dec 19, 2022 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 17, 2022 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 21, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 20, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 20, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 27, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2019 RCSC
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 21, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 21, 2019 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2019 RCSC
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 1, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2018 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 24, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2017 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 5, 2017 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 14, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 14, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jul 14, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 2, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 2, 2016 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2016 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2015 NWOS
NEW APPLICATION ENTERED
Sep 22, 2015 NWAP